Codiak BioSciences's total assets for Q were $134.40M, an increase of 1.27% from the previous quarter. CDAK total liabilities were $95.47M for the fiscal quarter, a 8.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.